Effect of metformin on Sirtuin-1 disorders associated with diabetes in male ratsFootnote

Peer review under responsibility of Alexandria University Faculty of Medicine.

Footnote

Available online 5 October 2017

References

• M.AfzalI.KazmiG.GuptaPreventive effect of Metformin against N-nitrosodiethylamine-initiated hepatocellular carcinoma in ratsSaudi Pharm J2042012365370
   Web of Science ®Google Scholar
• A.AlhaiderH.KorashyA.SayedMetformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expressionChem Biol Interact19232011233242
   PubMed Web of Science ®Google Scholar
• L.BordoneM.MottaF.PicardCorrection: Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic ß cellsPLoSBiol492006e295
   Web of Science ®Google Scholar
• G.BroskyJ.LogothetopoulosStreptozotocin diabetes in the mouse and guinea pigDiabetes81969606611
   Google Scholar
• G.BuckleyJ.CutlerJ.AlickSerum triglyceride: method of estimation and levels in normal humansCan Med Assoc J94171966886888
   PubMed Web of Science ®Google Scholar
• C.BurantM.TreutelaarM.BuseDiabetes-induced functional and structural changes in insulin receptors from rat skeletal muscleJ Clin Invest771986260270
   Web of Science ®Google Scholar
• C.CantoZ.Gerhart-HinesJ.FeigeAMPK regulates energy expenditure by modulating NADC metabolism and SIRT1 activityNature458200910561060
   PubMed Web of Science ®Google Scholar
• R.CarmenaHigh risk of lipoprotein dysfunction in type 2 diabetes mellitusRev Esp Cardiol8Suppl. C20081824
   Google Scholar
• P.CatonN.NayuniJ.KieswichMetformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5J Endocrinolog205201097106
   PubMed Web of Science ®Google Scholar
• Y.ChanBiostatistics 102: quantitative data – parametric & non-parametric testsSingapore Med J4482003391396
   PubMedGoogle Scholar
• F.ChenY.loannouQuantitation of DNA fragmentation in apoptosisOxford J Life Sci Nucl Acids Res2451996992993
   Web of Science ®Google Scholar
• D.CibulaM.FantaJ.VrbikovaThe effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patientsHum Reprod202005180184
   PubMed Web of Science ®Google Scholar
• R.De- FronzoM.Abdul-GhaniType 2 diabetes can be prevented with early pharmacological interventionDiabetes Care34Suppl. 22011S202S209
   Google Scholar
• J.DhahbiP.MoteG.FahyIdentification of potential caloric restriction mimetics by microarray profilingPhysiol Genomics2332005343350
   PubMed Web of Science ®Google Scholar
• Diabetes Prevention Program Research GroupThe prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention ProgramDiabet Med242007137144
   PubMed Web of Science ®Google Scholar
• M.DonathP.HalbanDecreased b-cell mass in diabetes: significance, mechanisms and therapeutic implicationsDiabetologia472004581589
   PubMed Web of Science ®Google Scholar
• J.DubuisC.DealR.TsagaroulisEffect of 14 days infusion of growth hormone and/ or insulin like growth factor-1 on the obesity of growing zuker ratsEndocrinology137199627992800
   Web of Science ®Google Scholar
• K.H.EffatA.LailaA.HananM.ManalE.FatmaIs the effect of caloric restriction on type 2 diabetes mellitus in rats mediated via Sirtuin-1?Med J Cairo Univ8312015357365
   Google Scholar
• M.EmotoY.NishizawaK.MaekawaHomeostasis Model Assessment as a Clinical index of insulin resistance in type 2 diabetic patients treated with SulfonylureasDiabetes Care221999818822
   PubMed Web of Science ®Google Scholar
• R.FlemingZ.HopkinsonA.WallaceOvarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trialJ ClinEndorinol Metab872002569574
   PubMed Web of Science ®Google Scholar
• L.FryerA.Parbu-PatelD.CarlingThe anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathwaysJ Biol Chem27720022522625232
   PubMed Web of Science ®Google Scholar
• Y.GalloisS.VolE.CacèsDistribution of fasting serum insulin measured by enzyme immunoassay in an unselected population of 4,032 individuals. Reference values according to age and sex. D.E.S.I.R. Study GroupDiabetes Metab2261996427431
   PubMed Web of Science ®Google Scholar
• R.GoldbergM.TemprosaJ.OtvosLifestyle and metformin treatment favorably influence lipoprotein subfraction distribution in the diabetes prevention programJ Clin Endocrinol Metab98102013
   Web of Science ®Google Scholar
• X.HouS.XuK.Maitland-ToolanSIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinaseJ Biol Chem2832920082001520026 18
   PubMed Web of Science ®Google Scholar
• R.HundalM.KrssakS.DufourMechanism by which metformin reduces glucose production in type 2diabetesDiabetes4200020632069
   Google Scholar
• T.KadowakiM.KasugaY.AkanumaDecreased autophosphorylation of the insulin receptor-kinase in streptozotocin-diabetic ratsJ Biol Chem25919841420814216
   PubMed Web of Science ®Google Scholar
• N.KalupahanaK.ClaycombeN.Moustaid-Moussa(n-3) Fatty acids alleviate adipose tissue inflammation and insulin resistance: mechanistic insightsAdv Nutrvol22011304316
   PubMed Web of Science ®Google Scholar
• Kenneth J.LivakThomas D.SchmittgenAnalysis of relative gene expression data using real-time quantitative PCR and the 22DDCTMethods252001402408
   PubMed Web of Science ®Google Scholar
• S.KimM.EllmererVan.CittersPrimacy of hepatic insulin resistance in the development of the metabolic syndrome induced by an isocaloric moderate-fat diet in the dogDiabetes52200324532460
   PubMed Web of Science ®Google Scholar
• M.KitadaS.KumeA.KeizoSirtuins as possible drug targets in type 2 diabetesCurr Drug Kanasaki Targets142013622636
   PubMed Web of Science ®Google Scholar
• W.KnowlerE.Barrett-ConnorS.FowlerReduction in the incidence of type 2 diabetes with lifestyle intervention or metforminN Engl J Med3462002393403
   PubMed Web of Science ®Google Scholar
• R.KraussLipids and lipoproteins in patients with type 2 diabetesDiabetes Care276200414961504
   PubMed Web of Science ®Google Scholar
• N.KumarC.DeyMetformin enhances insulin signalling in insulin-dependent and -independent pathways in insulin resistant muscle cellsBr J Pharmacol1372002329336
   PubMed Web of Science ®Google Scholar
• J.LeeM.SongB.ParkOverexpression of SIRT1 protects pancreatic β-cells against cytokine toxicity by suppressing the nuclear factor-κB signaling pathwayDiabetes5822009344351
   PubMed Web of Science ®Google Scholar
• I.LeibigerP.BerggrenSirt1: a metabolic master switch that modulates lifespanNat Med12120063436
   Web of Science ®Google Scholar
• R.MackenzieB.ElliottAkt/PKB activation and insulin signaling: a novel insulin signaling pathway in the treatment of type 2 diabetesDiabetes Metab Syndr Obes720145564
   PubMedGoogle Scholar
• E.MarkD.NicolasD.BronwynMetformin prevents the development of acute lipid-induced insulin resistance in the rat through altered hepatic signaling mechanismsDiabetes5312200432583266
   Web of Science ®Google Scholar
• G.MithieuxL.GuignotJ.BordetIntrahepatic mechanisms underlying the effect of metformin in decreasing basal glucose production in rats fed a high-fat dietDiabetes512002139143
   Web of Science ®Google Scholar
• Y.MiyazakiA.MahankaliM.MatsudaEffect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patientsJ Clin Endocrinol Metab87200227842791
   PubMed Web of Science ®Google Scholar
• N.MusiM.HirshmanJ.NygrenMetformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetesDiabetes51200220742081
   PubMed Web of Science ®Google Scholar
• S.PaulW.RobertD.KellyDetermination of high density lipoprotein- cholesterol in stored human plasmaJ Lipid Res211980
   Web of Science ®Google Scholar
• G.PerrielloS.PampanelliP.Del SindacoEvidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDMDiabetes46199710101016
   PubMed Web of Science ®Google Scholar
• M.PfafflA new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Res292001e45
   PubMed Web of Science ®Google Scholar
• J.RadziukC.BaileyN.WiernspergerMetformin and its liver targets in the treatment of type 2 diabetesCurr Drug Targets Immune Endocr Metabol Disord32003151169
   PubMedGoogle Scholar
• K.RautioJ.TapanainenA.RuokonenEffects of metformin and ethinyl estradiol-cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndromeEur J Endocrinol1522005269275
   PubMed Web of Science ®Google Scholar
• C.RhodesType 2 diabetes–a matter of b-cell life and death?Science3072005380384
   PubMed Web of Science ®Google Scholar
• B.RoginaS.HelfandSir2 mediates longevity in the fly through a pathway related to calorie restrictionProc Natl Acad Sci USA10120041599816003
   PubMed Web of Science ®Google Scholar
• V.SamuelZ.LiuX.QuMechanism of hepatic insulin resistance in non-alcoholic fatty liver diseaseJ Biol Chem27920043234532353
   PubMed Web of Science ®Google Scholar
• C.SebastiánF.KyleM.HaigisFrom Sirtuin biology to human diseases: an updateJ Biol Chem28720124244442452
   PubMed Web of Science ®Google Scholar
• B.SuvarnaSirtuins: the future insightMed J38220127782
   Google Scholar
• S.TabishIs diabetes becoming the biggest epidemic of the twenty-first century?Int J Health Sci (Qassim)122007VVIII
   PubMedGoogle Scholar
• J.TakadaM.MachadoS.PeresNeonatal streptozotocin-induced diabetes mellitus: a model of insulin resistance associated with loss of adipose massMetabolism5672007977984
   Web of Science ®Google Scholar
• P.TrinderEvaluation of Trinder glucose oxidase methodClinchem2112197517541760
   Google Scholar
• R.WangH.KimX.CuiyingHepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistanceJ Clin Invest12111201144774490
   PubMed Web of Science ®Google Scholar
• D.WeiR.TaoY.ZhangFeedback regulation of hepatic gluconeogenesis through modulation of SHP/Nr0b2 gene expression by Sirt1 and FoxO1Am J Physiol Endocrinol Metab30022011E312E320
   Web of Science ®Google Scholar
• H.YangX.JinL.KeiOxidative stress and diabetes mellitusClinChem, Lab Med.4911201117731782
   Google Scholar
• T.YoshizakiS.SchenkT.ImamuraSIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivityAm J Physiol Endocrinol Metab2982010E419E428
   PubMed Web of Science ®Google Scholar
• G.ZhanguoY.JianpingBiochem Biophys Res Commun37642008793796
   Web of Science ®Google Scholar